{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T09:38:18Z","timestamp":1787564298997,"version":"build-2736575974"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,5,2]],"date-time":"2022-05-02T00:00:00Z","timestamp":1651449600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,5,2]],"date-time":"2022-05-02T00:00:00Z","timestamp":1651449600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Most structurally characterized broadly neutralizing antibodies (bnAbs) against influenza A viruses (IAVs) target the conserved conformational epitopes of hemagglutinin (HA). Here, we report a lineage of naturally occurring human antibodies sharing the same germline gene, V\n                    <jats:sub>H<\/jats:sub>\n                    3-48\/V\n                    <jats:sub>K<\/jats:sub>\n                    1-12. These antibodies broadly neutralize the major circulating strains of IAV in vitro and in vivo mainly by binding a contiguous epitope of H3N2 HA, but a conformational epitope of H1N1 HA, respectively. Our structural and functional studies of antibody 28-12 revealed that the continuous amino acids in helix A, particularly N49\n                    <jats:sub>HA2<\/jats:sub>\n                    of H3 HA, are critical to determine the binding feature with 28-12. In contrast, the conformational epitope feature is dependent on the discontinuous segments involving helix A, the fusion peptide, and several HA1 residues within H1N1 HA. We report that this antibody was initially selected by H3 (group 2) viruses and evolved via somatic hypermutation to enhance the reactivity to H3 and acquire cross-neutralization to H1 (group 1) virus. These findings enrich our understanding of different antigenic determinants of heterosubtypic influenza viruses for the recognition of bnAbs and provide a reference for the design of influenza vaccines and more effective antiviral drugs.\n                  <\/jats:p>","DOI":"10.1038\/s41467-022-29950-w","type":"journal-article","created":{"date-parts":[[2022,5,2]],"date-time":"2022-05-02T06:03:01Z","timestamp":1651471381000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Unique binding pattern for a lineage of human antibodies with broad reactivity against influenza A virus"],"prefix":"10.1038","volume":"13","author":[{"given":"Xiaoyu","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caixuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8873-6773","authenticated-orcid":false,"given":"Zhiyang","family":"Ling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunyan","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingliang","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8713-9923","authenticated-orcid":false,"given":"Wenshuai","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shubing","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangfang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonam","family":"Wangmo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuangfeng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liyan","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2417-6516","authenticated-orcid":false,"given":"Yaguang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuo","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1566-8447","authenticated-orcid":false,"given":"Xiaoping","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhikang","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7029-7346","authenticated-orcid":false,"given":"Jianping","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4990-1016","authenticated-orcid":false,"given":"Dayan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7164-8694","authenticated-orcid":false,"given":"Yao","family":"Cong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2545-5282","authenticated-orcid":false,"given":"Bing","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,5,2]]},"reference":[{"key":"29950_CR1","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.chom.2018.06.016","volume":"24","author":"L Coughlan","year":"2018","unstructured":"Coughlan, L. & Palese, P. Overcoming barriers in the path to a universal influenza virus vaccine. Cell Host Microbe 24, 18\u201324 (2018).","journal-title":"Cell Host Microbe"},{"key":"29950_CR2","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1038\/nrmicro2613","volume":"9","author":"RA Medina","year":"2011","unstructured":"Medina, R. A. & Garcia-Sastre, A. Influenza A viruses: new research developments. Nat. Rev. Microbiol 9, 590\u2013603 (2011).","journal-title":"Nat. Rev. Microbiol"},{"key":"29950_CR3","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1038\/s41577-019-0143-6","volume":"19","author":"F Krammer","year":"2019","unstructured":"Krammer, F. The human antibody response to influenza A virus infection and vaccination. Nat. Rev. Immunol. 19, 383\u2013397 (2019).","journal-title":"Nat. Rev. Immunol."},{"key":"29950_CR4","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/0042-6822(91)90588-3","volume":"182","author":"E Nobusawa","year":"1991","unstructured":"Nobusawa, E. et al. Comparison of complete amino acid sequences and receptor-binding properties among 13 serotypes of hemagglutinins of influenza A viruses. Virology 182, 475\u2013485 (1991).","journal-title":"Virology"},{"key":"29950_CR5","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1097\/00006454-199903000-00004","volume":"18","author":"HC Meissner","year":"1999","unstructured":"Meissner, H. C. et al. Immunoprophylaxis with palivizumab, a humanized respiratory syncytial virus monoclonal antibody, for prevention of respiratory syncytial virus infection in high risk infants: a consensus opinion. Pediatr. Infect. Dis. J. 18, 223\u2013231 (1999).","journal-title":"Pediatr. Infect. Dis. J."},{"key":"29950_CR6","doi-asserted-by":"publisher","first-page":"4269","DOI":"10.1073\/pnas.1116200109","volume":"109","author":"S Tong","year":"2012","unstructured":"Tong, S. et al. A distinct lineage of influenza A virus from bats. Proc. Natl Acad. Sci. USA 109, 4269\u20134274 (2012).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"29950_CR7","doi-asserted-by":"publisher","first-page":"e1003657","DOI":"10.1371\/journal.ppat.1003657","volume":"9","author":"S Tong","year":"2013","unstructured":"Tong, S. et al. New world bats harbor diverse influenza A viruses. PLoS Pathog. 9, e1003657 (2013).","journal-title":"PLoS Pathog."},{"key":"29950_CR8","doi-asserted-by":"crossref","unstructured":"Sutton, T. C. The pandemic threat of emerging H5 and H7 avian influenza viruses. Viruses 10, 461 (2018).","DOI":"10.3390\/v10090461"},{"key":"29950_CR9","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1016\/j.cell.2016.05.073","volume":"166","author":"NL Kallewaard","year":"2016","unstructured":"Kallewaard, N. L. et al. Structure and function analysis of an antibody recognizing all influenza A subtypes. Cell 166, 596\u2013608 (2016).","journal-title":"Cell"},{"key":"29950_CR10","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1126\/science.1154137","volume":"320","author":"CA Russell","year":"2008","unstructured":"Russell, C. A. et al. The global circulation of seasonal influenza A (H3N2) viruses. Science 320, 340\u2013346 (2008).","journal-title":"Science"},{"key":"29950_CR11","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1146\/annurev.biochem.69.1.531","volume":"69","author":"JJ Skehel","year":"2000","unstructured":"Skehel, J. J. & Wiley, D. C. Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin. Annu Rev. Biochem 69, 531\u2013569 (2000).","journal-title":"Annu Rev. Biochem"},{"key":"29950_CR12","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms13577","volume":"7","author":"W Wang","year":"2016","unstructured":"Wang, W. et al. Human antibody 3E1 targets the HA stem region of H1N1 and H5N6 influenza A viruses. Nat. Commun. 7, 13577 (2016).","journal-title":"Nat. Commun."},{"key":"29950_CR13","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1126\/science.1222908","volume":"337","author":"C Dreyfus","year":"2012","unstructured":"Dreyfus, C. et al. Highly conserved protective epitopes on influenza B viruses. Science 337, 1343\u20131348 (2012).","journal-title":"Science"},{"key":"29950_CR14","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.chom.2013.06.004","volume":"14","author":"G Nakamura","year":"2013","unstructured":"Nakamura, G. et al. An in vivo human-plasmablast enrichment technique allows rapid identification of therapeutic influenza A antibodies. Cell Host Microbe 14, 93\u2013103 (2013).","journal-title":"Cell Host Microbe"},{"key":"29950_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms8708","volume":"6","author":"Y Wu","year":"2015","unstructured":"Wu, Y. et al. A potent broad-spectrum protective human monoclonal antibody crosslinking two haemagglutinin monomers of influenza A virus. Nat. Commun. 6, 7708 (2015).","journal-title":"Nat. Commun."},{"key":"29950_CR16","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1126\/science.1205669","volume":"333","author":"D Corti","year":"2011","unstructured":"Corti, D. et al. A neutralizing antibody selected from plasma cells that binds to group 1 and group 2 influenza A hemagglutinins. Science 333, 850\u2013856 (2011).","journal-title":"Science"},{"key":"29950_CR17","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1016\/j.cell.2019.04.011","volume":"177","author":"S Bangaru","year":"2019","unstructured":"Bangaru, S. et al. A site of vulnerability on the influenza virus hemagglutinin head domain trimer interface. Cell 177, 1136\u20131152 (2019).","journal-title":"Cell"},{"key":"29950_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-20879-6","volume":"12","author":"WD Harshbarger","year":"2021","unstructured":"Harshbarger, W. D. et al. Unique structural solution from a VH3-30 antibody targeting the hemagglutinin stem of influenza A viruses. Nat. Commun. 12, 559 (2021).","journal-title":"Nat. Commun."},{"key":"29950_CR19","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1038\/nature13764","volume":"516","author":"L Pappas","year":"2014","unstructured":"Pappas, L. et al. Rapid development of broadly influenza neutralizing antibodies through redundant mutations. Nature 516, 418\u2013422 (2014).","journal-title":"Nature"},{"key":"29950_CR20","first-page":"316ra192","volume":"7","author":"SF Andrews","year":"2015","unstructured":"Andrews, S. F. et al. Immune history profoundly affects broadly protective B cell responses to influenza. Sci. Transl. Med 7, 316ra192 (2015).","journal-title":"Sci. Transl. Med"},{"key":"29950_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-40175-8","volume":"9","author":"G Bajic","year":"2019","unstructured":"Bajic, G. et al. Autoreactivity profiles of influenza hemagglutinin broadly neutralizing antibodies. Sci. Rep. 9, 3492 (2019).","journal-title":"Sci. Rep."},{"key":"29950_CR22","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1038\/nmeth.4347","volume":"14","author":"YZ Tan","year":"2017","unstructured":"Tan, Y. Z. et al. Addressing preferred specimen orientation in single-particle cryo-EM through tilting. Nat. Methods 14, 793\u2013796 (2017).","journal-title":"Nat. Methods"},{"key":"29950_CR23","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1126\/science.1204839","volume":"333","author":"DC Ekiert","year":"2011","unstructured":"Ekiert, D. C. et al. A highly conserved neutralizing epitope on group 2 influenza A viruses. Science 333, 843\u2013850 (2011).","journal-title":"Science"},{"key":"29950_CR24","doi-asserted-by":"crossref","unstructured":"Bai, L. et al. Coinfection with influenza A virus enhances SARS-CoV-2 infectivity. Cell Res. (2021).","DOI":"10.1038\/s41422-021-00473-1"},{"key":"29950_CR25","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s11596-021-2317-2","volume":"41","author":"X Xiang","year":"2021","unstructured":"Xiang, X. et al. Co-infection of SARS-COV-2 and influenza a virus: a case series and fast review. Curr. Med Sci. 41, 51\u201357 (2021).","journal-title":"Curr. Med Sci."},{"key":"29950_CR26","doi-asserted-by":"publisher","first-page":"e84","DOI":"10.1016\/S0140-6736(20)31052-7","volume":"395","author":"E Cuadrado-Payan","year":"2020","unstructured":"Cuadrado-Payan, E. et al. SARS-CoV-2 and influenza virus co-infection. Lancet 395, e84 (2020).","journal-title":"Lancet"},{"key":"29950_CR27","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1038\/nbt.3907","volume":"35","author":"EM Strauch","year":"2017","unstructured":"Strauch, E. M. et al. Computational design of trimeric influenza-neutralizing proteins targeting the hemagglutinin receptor binding site. Nat. Biotechnol. 35, 667\u2013671 (2017).","journal-title":"Nat. Biotechnol."},{"key":"29950_CR28","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1126\/science.aan0516","volume":"358","author":"RU Kadam","year":"2017","unstructured":"Kadam, R. U. et al. Potent peptidic fusion inhibitors of influenza virus. Science 358, 496\u2013502 (2017).","journal-title":"Science"},{"key":"29950_CR29","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/j.cell.2016.06.043","volume":"166","author":"MG Joyce","year":"2016","unstructured":"Joyce, M. G. et al. Vaccine-induced antibodies that neutralize group 1 and group 2 influenza A viruses. Cell 166, 609\u2013623 (2016).","journal-title":"Cell"},{"key":"29950_CR30","doi-asserted-by":"crossref","unstructured":"Andrews, S. F. et al. Preferential induction of cross-group influenza A hemagglutinin stem-specific memory B cells after H7N9 immunization in humans. Sci Immunol. 2, eaan2676 (2017).","DOI":"10.1126\/sciimmunol.aan2676"},{"key":"29950_CR31","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.immuni.2017.12.009","volume":"48","author":"KR McCarthy","year":"2018","unstructured":"McCarthy, K. R. et al. Memory B cells that cross-react with group 1 and group 2 influenza A viruses are abundant in adult human repertoires. Immunity 48, 174\u2013184 (2018).","journal-title":"Immunity"},{"key":"29950_CR32","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1038\/nm.3743","volume":"21","author":"BJ DeKosky","year":"2015","unstructured":"DeKosky, B. J. et al. In-depth determination and analysis of the human paired heavy- and light-chain antibody repertoire. Nat. Med 21, 86\u201391 (2015).","journal-title":"Nat. Med"},{"key":"29950_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms12780","volume":"7","author":"Y Fu","year":"2016","unstructured":"Fu, Y. et al. A broadly neutralizing anti-influenza antibody reveals ongoing capacity of haemagglutinin-specific memory B cells to evolve. Nat. Commun. 7, 12780 (2016).","journal-title":"Nat. Commun."},{"key":"29950_CR34","doi-asserted-by":"publisher","first-page":"e1000350","DOI":"10.1371\/journal.ppat.1000350","volume":"5","author":"R Yoshida","year":"2009","unstructured":"Yoshida, R. et al. Cross-protective potential of a novel monoclonal antibody directed against antigenic site B of the hemagglutinin of influenza A viruses. PLoS Pathog. 5, e1000350 (2009).","journal-title":"PLoS Pathog."},{"key":"29950_CR35","doi-asserted-by":"publisher","first-page":"10905","DOI":"10.1128\/JVI.00700-11","volume":"85","author":"JC Krause","year":"2011","unstructured":"Krause, J. C. et al. A broadly neutralizing human monoclonal antibody that recognizes a conserved, novel epitope on the globular head of the influenza H1N1 virus hemagglutinin. J. Virol. 85, 10905\u201310908 (2011).","journal-title":"J. Virol."},{"key":"29950_CR36","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.virol.2012.09.034","volume":"435","author":"W Hu","year":"2013","unstructured":"Hu, W. et al. Fully human broadly neutralizing monoclonal antibodies against influenza A viruses generated from the memory B cells of a 2009 pandemic H1N1 influenza vaccine recipient. Virology 435, 320\u2013328 (2013).","journal-title":"Virology"},{"key":"29950_CR37","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.jsb.2005.07.007","volume":"152","author":"DN Mastronarde","year":"2005","unstructured":"Mastronarde, D. N. Automated electron microscope tomography using robust prediction of specimen movements. J. Struct. Biol. 152, 36\u201351 (2005).","journal-title":"J. Struct. Biol."},{"key":"29950_CR38","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1107\/S2059798316019276","volume":"73","author":"R Fernandez-Leiro","year":"2017","unstructured":"Fernandez-Leiro, R. & Scheres, S. H. W. A pipeline approach to single-particle processing in RELION. Acta Crystallogr. Sect. D.-Struct. Biol. 73, 496\u2013502 (2017).","journal-title":"Acta Crystallogr. Sect. D.-Struct. Biol."},{"key":"29950_CR39","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1038\/nmeth.4193","volume":"14","author":"SQ Zheng","year":"2017","unstructured":"Zheng, S. Q. et al. MotionCor2: anisotropic correction of beam-induced motion for improved cryo-electron microscopy. Nat. Methods 14, 331\u2013332 (2017).","journal-title":"Nat. Methods"},{"key":"29950_CR40","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.jsb.2015.08.008","volume":"192","author":"A Rohou","year":"2015","unstructured":"Rohou, A. & Grigorieff, N. CTFFIND4: Fast and accurate defocus estimation from electron micrographs. J. Struct. Biol. 192, 216\u2013221 (2015).","journal-title":"J. Struct. Biol."},{"key":"29950_CR41","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.jsb.2018.11.012","volume":"205","author":"M Su","year":"2019","unstructured":"Su, M. goCTF: Geometrically optimized CTF determination for single-particle cryo-EM. J. Struct. Biol. 205, 22\u201329 (2019).","journal-title":"J. Struct. Biol."},{"key":"29950_CR42","doi-asserted-by":"crossref","unstructured":"Sanchez-Garcia, R., et al. DeepEMhancer: a deep learning solution for cryo-EM volume post-processing. Commun Biol 4, 874 (2021).","DOI":"10.1038\/s42003-021-02399-1"},{"key":"29950_CR43","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1038\/nmeth.2727","volume":"11","author":"A Kucukelbir","year":"2014","unstructured":"Kucukelbir, A., Sigworth, F. J. & Tagare, H. D. Quantifying the local resolution of cryo-EM density maps. Nat. Methods 11, 63\u201365 (2014).","journal-title":"Nat. Methods"},{"key":"29950_CR44","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/nmeth.4169","volume":"14","author":"A Punjani","year":"2017","unstructured":"Punjani, A., Rubinstein, J. L., Fleet, D. J. & Brubaker, M. A. cryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination. Nat. Methods 14, 290 (2017).","journal-title":"Nat. Methods"},{"key":"29950_CR45","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1093\/bioinformatics\/bti770","volume":"22","author":"K Arnold","year":"2006","unstructured":"Arnold, K., Bordoli, L., Kopp, J. & Schwede, T. The SWISS-MODEL workspace: a web-based environment for protein structure homology modelling. Bioinformatics 22, 195\u2013201 (2006).","journal-title":"Bioinformatics"},{"key":"29950_CR46","doi-asserted-by":"crossref","unstructured":"Fukuzawa, T. et al. Long lasting neutralization of C5 by SKY59, a novel recycling antibody, is a potential therapy for complement-mediated diseases. Sci Rep 7, 1\u201317 (2017).","DOI":"10.1038\/s41598-017-01087-7"},{"key":"29950_CR47","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1126\/science.1204839","volume":"333","author":"DC Ekiert","year":"2011","unstructured":"Ekiert, D. C. et al. A highly conserved neutralizing epitope on group 2 influenza A viruses. Science 333, 843\u2013850 (2011).","journal-title":"Science"},{"key":"29950_CR48","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.jsb.2011.09.006","volume":"179","author":"Z Yang","year":"2012","unstructured":"Yang, Z. et al. UCSF Chimera, MODELLER, and IMP: an integrated modeling system. J. Struct. Biol. 179, 269\u2013278 (2012).","journal-title":"J. Struct. Biol."},{"key":"29950_CR49","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1038\/nmeth.3286","volume":"12","author":"F DiMaio","year":"2015","unstructured":"DiMaio, F. et al. Atomic-accuracy models from 4.5-A cryo-electron microscopy data with density-guided iterative local refinement. Nat. methods 12, 361\u2013365 (2015).","journal-title":"Nat. methods"},{"key":"29950_CR50","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1107\/S0907444909052925","volume":"66","author":"PD Adams","year":"2010","unstructured":"Adams, P. D. et al. PHENIX: a comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr D. 66, 213\u2013221 (2010).","journal-title":"Acta Crystallogr D."},{"key":"29950_CR51","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.1107\/S0907444904019158","volume":"60","author":"P Emsley","year":"2004","unstructured":"Emsley, P. & Cowtan, K. Coot: model-building tools for molecular graphics. Acta Crystallogr. Sect. D.-Biol. Crystallogr. 60, 2126\u20132132 (2004).","journal-title":"Acta Crystallogr. Sect. D.-Biol. Crystallogr."},{"key":"29950_CR52","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1002\/jcc.20084","volume":"25","author":"EF Pettersen","year":"2004","unstructured":"Pettersen, E. F. et al. UCSF chimera - A visualization system for exploratory research and analysis. J. Computational Chem. 25, 1605\u20131612 (2004).","journal-title":"J. Computational Chem."},{"key":"29950_CR53","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1002\/pro.3235","volume":"27","author":"TD Goddard","year":"2018","unstructured":"Goddard, T. D. et al. UCSF ChimeraX: Meeting modern challenges in visualization and analysis. Protein Sci. 27, 14\u201325 (2018).","journal-title":"Protein Sci."},{"key":"29950_CR54","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1002\/prot.25744","volume":"87","author":"S Schlee","year":"2019","unstructured":"Schlee, S. et al. Prediction of quaternary structure by analysis of hot spot residues in protein-protein interfaces: the case of anthranilate phosphoribosyltransferases. Proteins 87, 815\u2013825 (2019).","journal-title":"Proteins"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-29950-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-29950-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-29950-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,24]],"date-time":"2022-11-24T12:11:24Z","timestamp":1669291884000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-29950-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,2]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["29950"],"URL":"https:\/\/doi.org\/10.1038\/s41467-022-29950-w","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,2]]},"assertion":[{"value":"2 July 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 April 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 May 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"B.S., X.S., X.L., and Z.L. are inventors on the patent application of antibody 28-12. The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2378"}}